A. VEST and CHASM p-values for co-occurring RAD52 mutations listed in Table 1. For easy identification each mutation is highlighted by a different color. Those with significant p-values are indicated with one star (either VEST or CHASM) or two stars (both). B. VEST and CHASM p-values for co-occurring BRCA2 mutations listed in Table 1. For easy identification each mutation is highlighted by a different color. Those with significant p-values are indicated with one star (either VEST or CHASM) or two stars (both). C. VEST and CHASM p-values for co-occurring BRCA1 mutations listed in Table 1. For easy identification each mutation is highlighted by a different color. Those with significant p-values are indicated with one star (either VEST or CHAS...
Somatic mutations were determined using paired OCSCC tumor/somatic DNA samples (n = 25), and defined...
Contains fulltext : 79746.pdf (publisher's version ) (Open Access)BACKGROUND: Asse...
<p>A) Heatmap of number of variants per tumour group. On the y-axis the different primary tumour sit...
A. Percent co-occurring mutations between the four genes using data from Table 1. Total percentage (...
Cartoon diagrams of RAD52, BRCA2, BRCA1 and PALB2 showing specific domains in each gene. The diagram...
<p>(A) the frequency (blue) and GERP score (red) distribution across the 528 mutations in TCGA BRCA ...
Mutation frequency within each cancer type ranges from light red (0%) to dark red (≥ 10% of samples)...
Section A. Comparison with other methods for discovering single driver mutation. Section B. Paramete...
<p>Cancer driver mutations identified in uterine lavage samples and their comparison to TCGA statist...
In these figures, the “ICGC-IntOgen,” for example, denotes a set of mutations as an intersection of ...
Tumor-type-specific posterior distributions of mutational selection coefficients (MSCs) and EAP (exp...
Figure S2. Hotspot mutation and CCF. (a) Maximum value of CCF in COADREAD. Each dot means a tumor pa...
<p>The <i>CRP</i>-286 SNP mutations show no association with mutated <i>p53</i> or <i>K-ras</i> in c...
There is considerable evidence indicating that disease risk in carriers of high-risk mutations (e.g....
There is considerable evidence indicating that disease risk in carriers of high-risk mutations (e.g....
Somatic mutations were determined using paired OCSCC tumor/somatic DNA samples (n = 25), and defined...
Contains fulltext : 79746.pdf (publisher's version ) (Open Access)BACKGROUND: Asse...
<p>A) Heatmap of number of variants per tumour group. On the y-axis the different primary tumour sit...
A. Percent co-occurring mutations between the four genes using data from Table 1. Total percentage (...
Cartoon diagrams of RAD52, BRCA2, BRCA1 and PALB2 showing specific domains in each gene. The diagram...
<p>(A) the frequency (blue) and GERP score (red) distribution across the 528 mutations in TCGA BRCA ...
Mutation frequency within each cancer type ranges from light red (0%) to dark red (≥ 10% of samples)...
Section A. Comparison with other methods for discovering single driver mutation. Section B. Paramete...
<p>Cancer driver mutations identified in uterine lavage samples and their comparison to TCGA statist...
In these figures, the “ICGC-IntOgen,” for example, denotes a set of mutations as an intersection of ...
Tumor-type-specific posterior distributions of mutational selection coefficients (MSCs) and EAP (exp...
Figure S2. Hotspot mutation and CCF. (a) Maximum value of CCF in COADREAD. Each dot means a tumor pa...
<p>The <i>CRP</i>-286 SNP mutations show no association with mutated <i>p53</i> or <i>K-ras</i> in c...
There is considerable evidence indicating that disease risk in carriers of high-risk mutations (e.g....
There is considerable evidence indicating that disease risk in carriers of high-risk mutations (e.g....
Somatic mutations were determined using paired OCSCC tumor/somatic DNA samples (n = 25), and defined...
Contains fulltext : 79746.pdf (publisher's version ) (Open Access)BACKGROUND: Asse...
<p>A) Heatmap of number of variants per tumour group. On the y-axis the different primary tumour sit...